General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Cash Flows

v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Dec. 31, 2016
Operating Activities:        
Net loss $ (8,192,523) $ (4,849,474) $ (7,266,553) $ (4,274,105)
Adjustments to reconcile net loss to net cash used in operating activities:        
Share-based compensation 2,960,733 1,824,045 2,533,245 1,301,402
Change in fair value of derivative liability 839,872 (5,900)
Amortization of debt discount 747,623 174,981 418,339 404,041
Conversion of Series A 118,698 217,106
Debt extinguishment costs, net 423,028 977,201 977,203 455,975
Financing costs 171,739 643,481
Depreciation and amortization 15,823 16,090 21,512 21,301
Effect of changes in assets and liabilities:        
Accounts payable, accrued expenses, and accrued interest 253,289 569,881 799,144 456,774
Deferred revenue 2,694    
Other assets 1,286 7,256 7,256 (16,036)
Accounts receivable (2,500) 2,468 8,468 (8,417)
Prepaid expenses (22,469) (15,680) (30,038) 55,052
Net cash used in operating activities (2,801,405) (1,174,534) (1,676,737) (1,604,013)
Investing Activities:        
Purchase of property and equipment     (2,494)
Other    
Net cash used in investing activities     (2,494)
Financing Activities:        
Proceeds from sale of common stock 2,978,500 470,000 796,000 1,524,030
Proceeds from exercise of put option 1,000,000 50,000  
Proceeds from convertible note payable 130,000 813,000
Proceeds from option exercise 34,133    
Proceeds from warrant exercise 22,000    
Proceeds from series A preferred stock 555,000 555,000
Proceeds / (payment) of convertible notes payable (845,000) 300,000    
Redemption of series A preferred (138,322) (543,465)
Repurchase common stock (20,000) (166,226)
Deferred offering costs (129,327)    
Proceeds from note payable     80,000
Proceeds from notes payable - related parties     92,446
Payment of notes payable - related parties     (10,000)
Net cash provided by financing activities 3,170,306 1,186,678 1,670,535 1,520,250
Net change in cash 368,901 12,144 (6,202) (86,257)
Cash - beginning of period 10,560 16,762 16,762 103,019
Cash - end of period 379,461 28,906 10,560 16,762
Supplemental disclosures of cash flow information:        
Cash paid for interest 369,597 171,375 326,221 129,869
Cash paid for income taxes 800 1,600 800
Supplemental disclosure of non-cash investing and financing activities:        
Conversion of note payable and accrued interest to common stock 3,065,837 181,845  
Common stock issued to settle accrued officers salary 582,333 180,686
Fair value of derivative liability, common shares, warrants and beneficial conversion feature of issued convertible note 150,000 196,953 154,350
Conversion of notes payable to common stock 181,845 181,845
Common stock issued to settle accounts payable 56,000 56,000
Conversion of series A Preferred to common stock $ 263,876 303,641
Fair value of derivative liability from issuance of convertible debt and warrant features $ 301,739    
Fair value of warrants issued and beneficial conversion feature to extinguish debt     860,601
Conversion of accrued interest on notes payable to related parties note     10,900
Conversion of accrued payroll to related party note     121,875
Conversion of accrued interest on notes payable to convertible notes payable     $ 80,268